157 related articles for article (PubMed ID: 21912777)
1. Options for intensifying diabetes treatment.
Reid TS
J Fam Pract; 2011 Sep; 60(9 Suppl):S7-10. PubMed ID: 21912777
[No Abstract] [Full Text] [Related]
2. Type 2 diabetes: target HbA1c of about 7%.
Prescrire Int; 2009 Aug; 18(102):177. PubMed ID: 19746575
[TBL] [Abstract][Full Text] [Related]
3. Diabetes specialists keep ACCORD data in perspective.
Traynor K
Am J Health Syst Pharm; 2008 Mar; 65(6):488, 490. PubMed ID: 18319488
[No Abstract] [Full Text] [Related]
4. Understanding the inter-relationship between improved glycaemic control, hypoglycaemia and weight change within a long-term economic model.
McEwan P; Evans M; Kan H; Bergenheim K
Diabetes Obes Metab; 2010 May; 12(5):431-6. PubMed ID: 20415691
[TBL] [Abstract][Full Text] [Related]
5. Glycemic control in type 2 diabetes mellitus.
Quevedo SF; Westrick E
Med Health R I; 1998 Nov; 81(11):345-8. PubMed ID: 15580787
[No Abstract] [Full Text] [Related]
6. Intensifying type 2 diabetes therapy: assessing the options. Introduction.
Brunton SA
J Fam Pract; 2011 Sep; 60(9 Suppl):S3. PubMed ID: 21912772
[No Abstract] [Full Text] [Related]
7. Insulin management of type 2 diabetes mellitus.
Petznick A
Am Fam Physician; 2011 Jul; 84(2):183-90. PubMed ID: 21766768
[TBL] [Abstract][Full Text] [Related]
8. Initial therapy for type 2 diabetes. Examination of a combination approach.
Henson K; Hight R; Welborn D; Wyatt S
Adv Nurse Pract; 2009 Jun; 17(6):43-4. PubMed ID: 20000183
[No Abstract] [Full Text] [Related]
9. Insulin for intensifying diabetes treatment.
Meneghini LF
J Fam Pract; 2011 Sep; 60(9 Suppl):S21-8. PubMed ID: 21912774
[No Abstract] [Full Text] [Related]
10. Health and economic effects of adding nateglinide to metformin to achieve dual control of glycosylated hemoglobin and postprandial glucose levels in a model of type 2 diabetes mellitus.
Salas M; Ward A; Caro J
Clin Ther; 2002 Oct; 24(10):1690-705. PubMed ID: 12462297
[TBL] [Abstract][Full Text] [Related]
11. Intensified glucose control in type 2 diabetes--whose agenda?
Yudkin JS; Richter B; Gale EA
Lancet; 2011 Apr; 377(9773):1220-2. PubMed ID: 21093903
[No Abstract] [Full Text] [Related]
12. [Metformin efficacious in poorly controlled diabetes mellitus type 2].
Stades AM; Holleman F; Hoekstra JB
Ned Tijdschr Geneeskd; 2000 Sep; 144(40):1897-900. PubMed ID: 11045134
[TBL] [Abstract][Full Text] [Related]
13. Pivotal role of timely basal insulin replacement after metformin failure in sustaining long-term blood glucose control at a target in type 2 diabetes.
Bolli GB; Lucidi P; Porcellati F; Fanelli CG
Diabetes Care; 2011 May; 34 Suppl 2(Suppl 2):S220-4. PubMed ID: 21525459
[No Abstract] [Full Text] [Related]
14. DPP-4 inhibitors in the management of type 2 diabetes: a critical review of head-to-head trials.
Scheen AJ
Diabetes Metab; 2012 Apr; 38(2):89-101. PubMed ID: 22197148
[TBL] [Abstract][Full Text] [Related]
15. Glyburide/metformin HCl clinical overview.
Seymour A
Manag Care; 2001 Feb; 10(2 Suppl):11-6. PubMed ID: 11729403
[No Abstract] [Full Text] [Related]
16. Overview of insulin replacement therapy.
Wright EE
J Fam Pract; 2009 Aug; 58(8 Suppl):S3-9. PubMed ID: 19679029
[No Abstract] [Full Text] [Related]
17. A summary of the ADVANCE Trial.
Heller SR;
Diabetes Care; 2009 Nov; 32 Suppl 2(Suppl 2):S357-61. PubMed ID: 19875581
[No Abstract] [Full Text] [Related]
18. Summaries for patients. The cost-effectiveness of strategies to prevent type 2 diabetes.
Ann Intern Med; 2005 Mar; 142(5):I28. PubMed ID: 15738446
[No Abstract] [Full Text] [Related]
19. Cost-effectiveness of rosiglitazone combination therapy for the treatment of type 2 diabetes mellitus in the UK.
Beale S; Bagust A; Shearer AT; Martin A; Hulme L
Pharmacoeconomics; 2006; 24 Suppl 1():21-34. PubMed ID: 16800160
[TBL] [Abstract][Full Text] [Related]
20. Economic model of first-line drug strategies to achieve recommended glycaemic control in newly diagnosed type 2 diabetes mellitus.
Ramsdell JW; Braunstein SN; Stephens JM; Bell CF; Botteman MF; Devine ST
Pharmacoeconomics; 2003; 21(11):819-37. PubMed ID: 12859222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
